AUDA
| 中文名称 | AUDA |
|---|---|
| 中文同义词 | 12-(3-(金刚烷-1-基)脲基)十二酸;化合物AUDA;化合物AUDA,10 MM DMSO 溶液;12-(3-adamantan-1-YL-Ureido)十二烷酸 |
| 英文名称 | AUDA |
| 英文同义词 | 12-(3-adamantan-1-yl-ureido)dodecanoic acid;AUDA;12-[[(tricyclo[3.3.1.13,7]dec-1-ylamino)carbonyl]amino]-dodecanoic acid;Dodecanoic acid, 12-[[(tricyclo[3.3.1.13,7]dec-1-ylamino)carbonyl]amino]-;Inhibitor,anti-inflammatory,epoxide,inhibit,hydrolase,sEH,activity,AUDA,soluble,Epoxide Hydrolase,VSMC;AUDA, 10 mM in DMSO;AUDA,≥98%;12-(3-adamantan-1-Y-L-Ureido)dodecaneacid |
| CAS号 | 479413-70-2 |
| 分子式 | C23H40N2O3 |
| 分子量 | 392.58 |
| EINECS号 | |
| 相关类别 | 抗体-二抗 |
| Mol文件 | 479413-70-2.mol |
| 结构式 |  |
AUDA 性质
| 熔点 | 114 °C(Solv: hexane (110-54-3)) |
|---|---|
| 沸点 | 592.7±19.0 °C(Predicted) |
| 密度 | 1.09±0.1 g/cm3(Predicted) |
| 储存条件 | Sealed in dry,Store in freezer, under -20°C |
| 溶解度 | DMSO：加热至60℃时≥10mg/mL |
| 形态 | 粉末 |
| 酸度系数(pKa) | 4.78±0.10(Predicted) |
| 颜色 | 白色至米色 |
| InChI | 1S/C23H40N2O3/c26-21(27)10-8-6-4-2-1-3-5-7-9-11-24-22(28)25-23-15-18-12-19(16-23)14-20(13-18)17-23/h18-20H,1-17H2,(H,26,27)(H2,24,25,28)/t18-,19+,20-,23- |
| InChIKey | XLGSEOAVLVTJDH-UKBVAGSOSA-N |
| SMILES | OC(=O)CCCCCCCCCCCNC(=O)NC12C[C@@H]3C[C@@H](C[C@@H](C3)C1)C2 |
AUDA (compound 43) 是一种有效的 soluble epoxide hydrolase (sEH) 的抑制剂，对小鼠sEH和人sEH的IC50值分别为18 nM和69 nM。AUDA具有抗炎活性，可降低MMP-9、IL-1β、TNF-α 和 TGF-β。AUDA还可下调 Smad3 和 p38 信号通路。
| Target | Value |
|
MMP-9
() | |
|
IL-1β
() | |
|
TNF-α
() | |
|
TGF-β
() | |
|
Smad3
() |
AUDA (0.3-10 μg/mL; 48 hours) dose-dependently suppresses the proliferation of rat VSMCs exposed to PDGF.
AUDA (0.3-10 μg/mL; 30 min) dose-dependently upregulats COX-2 expression.
AUDA (10, 50 and 100 μM) augments the migratory ability of HCAECs in a dose-dependent manner.
AUDA significantly increases the adhesion ability of HCAECs.
Cell Proliferation Assay
| Cell Line: | Vascular smooth muscle cell (VSMC) |
| Concentration: | 0.3, 1, 3, 10 μg/mL |
| Incubation Time: | 48 hours |
| Result: | Dose-dependently suppressed the proliferation of rat VSMCs exposed to PDGF. |
Western Blot Analysis
| Cell Line: | VSMC |
| Concentration: | 1, 3, 10, 30 μg/mL |
| Incubation Time: | 30 min |
| Result: | Dose-dependently upregulated COX-2 expression. |
AUDA (i.p.; 10 mg/kg; 14 days) reduces TNF-α, MMP-9 and IL-1β expression levels.
| Animal Model: | Male (wild-type) C57BL/6 mice (age, 4-6 weeks; weight, 18-20 g) |
| Dosage: | 10 mg/kg |
| Administration: | i.p.; 14 days |
| Result: | Reduced TNF-α, MMP-9 and IL-1β expression levels. |
安全信息
| WGK Germany | 3 |
|---|---|
| 存储类别 | 11 - 可燃固体 |
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026/03/03 | S0752 | AUDA AUDA | 479413-70-2 | 5mg | 970.12元 |
| 2026/03/03 | S0752 | AUDA | 479413-70-2 | 10mM (1mL in DMSO) | 1270元 |